Company:  ROCKWELL MEDICAL, INC. (RMTI)
Form Type:  8-K
Filing Date:  12/4/2012 
CIK:  0001041024 
Address:  30142 S WIXOM RD 
City, State, Zip:  WIXOM, Michigan 48393 
Telephone:  (248) 960-9009 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$10.11  
Change: 
-0.22 (-2.13%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$412.20M
Description of Business
Rockwell Medical, Inc., incorporated in the state of Michigan in 1996, is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis (also referred to as "dialysis"). Rockwell's lead investigational drug, Triferic�, also known as Soluble Ferric Pyrophosphate or SFP, delivers iron to the bone marrow in a non-invasive, physiologic manner to hemodialysis patients via dialysate during their regular dialysis treatment. We are preparing to submit a New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") in the first quarter of 2014 seeking marketing approval of Triferic�.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01 Entry into a Material Definitive Agreement.
    SECTION 2 FINANCIAL INFORMATION
      Item 2.03 Creation of a Direct Financial Obligation or an ...
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 10.49
BROKERAGE PARTNERS